(Q43640751)

25 November 2017

title

TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type (English)

1 reference

25 November 2017

1 reference

7

Holger Moch

1 reference

25 November 2017

Markus Rechsteiner

1

1 reference

25 November 2017

Anne-Katrin Zimmermann

2

1 reference

25 November 2017

Peter J Wild

3

1 reference

25 November 2017

Rosmarie Caduff

4

1 reference

25 November 2017

Adriana von Teichman

5

1 reference

25 November 2017

Daniel Fink

6

1 reference

25 November 2017

Aurelia Noske

8

1 reference

25 November 2017

publication date

18 August 2013

1 reference

Experimental and Molecular Pathology

25 November 2017

published in

1 reference

25 November 2017

volume

95

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

235-241

1 reference

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Integrated genomic analyses of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

The biology of ovarian cancer: new opportunities for translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

p53 mutation is infrequent in clear cell carcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

P53 mutation does not affect prognosis in ovarian epithelial malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Structural bioinformatics mutation analysis reveals genotype-phenotype correlations in von Hippel-Lindau disease and suggests molecular mechanisms of tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Reliable detection of subclonal single-nucleotide variants in tumour cell populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

7 January 2021

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Molecular characterization of 103 ovarian serous and mucinous tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.08.004

10.1016/J.YEXMP.2013.08.004

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference